Philips, following consultation with the Therapeutic Goods Administration (TGA), announced it is conducting an Urgent Product Defect Correction for specific devices in the sleep and respiratory care portfolio. For more information please click here or call 1800 009 579.
We turned the design over to the experts. The result is a patient-driven design sleep apnea solution. Introducing our most rigorously researched sleep therapy system. The blueprint for the Dream Family came from interviews with people who use CPAP technology every day, and the people who manage their treatment. It’s helping patients rediscover their dreams.
The Dream Family offers innovative, comprehensive sleep therapy technology with sleek, patient-driven design, and personalized tools to keep your patients engaged and using therapy. Designed to increase patient adoption, long term use and enhanced efficiencies so you can better attend to patient’s needs, the Dream Family can help your patients get the sleep they need while supporting your business goals.
High marks for performance, no marks on the bridge of the nose. Now, with convenient magnetic clips for enhanced ease of use.
1. 2015 User Preference Questionnaire, data on file. 2. Mask does not directly contact the bridge of the nose or nostrils. 3. In a retrospective review conducted by Philips Respironics of approximately 15,000 System One patients, patients who used SleepMapper, which has been rebranded DreamMapper, demonstrated 22% greater adherence to the therapy than patients who did not use SleepMapper. To see which therapy devices are compatible with DreamMapper, visit www.dreammapper.com/compatible .
You are about to visit a Philips global content page
ContinueYou are about to visit a Philips global content page
ContinueSelect country
Australia (English)
The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).
By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.
